3.4. Intraperitoneal Administration of Sclerostin Inhibits Tumor Growth and Prolongs Overall Survival in a Mouse Model of Subcutaneously Transplanted Murine Osteosarcoma. This evidence concerns the gene SOST and neoplasm.